Bydureon treats type 2 diabetes. Can cause nausea. Nausea most commonly happens when first starting Bydureon, but may become less over time.
Bydureon is a prescription medication that is used along with diet and exercise to treat type 2 diabetes. Bydureon belongs to a group of medications called incretin mimetics which work by helping the pancreas to secrete insulin when blood sugar levels are high. They also decrease the amount of sugar the liver produces and slow the emptying of the stomach.
Common side effects of Bydureon include nausea, vomiting, diarrhea, and low blood sugar.
Patient Ratings for Bydureon
How was your experience with Bydureon?
Bydureon Cautionary Labels
Uses of Bydureon
Bydureon Drug Class
Bydureon is part of the drug class:
Side Effects of Bydureon
Serious side effects have been reported with Bydureon. See "Drug Precautions" section.
The most common side effects with Bydureon include:
- nausea. Nausea most commonly happens when first starting Bydureon, but may become less over time.
- diarrhea or constipation
- feeling jittery
- acid stomach or indigestion
- itching at injection-site
This is not a complete list of Bydureon side effects. Ask your doctor or pharmacist for more information.
Tell your doctor about all the medicines you take including prescription and nonprescription medicines, vitamins, and herbal supplements. Bydureon slows stomach emptying and can affect medicines that need to pass through the stomach quickly. Bydureon may affect the way some medicines work and some other medicines may affect the way Bydureon works.
Especially tell your doctor if you take:
- insulin, or any other anti-diabetes medicines
- birth control pills that are taken by mouth (oral contraceptives). Bydureon may lower the amount of the medicine in your blood from your birth control pills and they may not work as well to prevent pregnancy. Take your birth control pills at least one hour before your injection of Bydureon. If you must take your birth control pills with food, take it with a meal or snack where you do not also take Bydureon.
- an antibiotic. Take antibiotic medicines at least one hour before taking Bydureon. If you must take your antibiotic with food, take it with a meal or snack where you do not also take Bydureon.
- warfarin sodium (Coumadin, Jantoven)
- a blood pressure medicine
- a water pill (diuretic)
- a pain medicine
- lovastatin (Altoprev, Mevacor, Advicor)
This is not a complete list of Bydureon drug interactions. Ask your doctor or pharmacist for more information.
Serious side effects may occur including:
Heart attack or stroke. It is not known whether Bydureon, or other anti-diabetes medications, increase your risk of a heart attack or stroke.
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar is higher if you take Bydureon with another medicine that can cause low blood sugar, such as a sulfonylurea. The dose of your sulfonylurea medicine may need to be lowered while you use Bydureon. Signs and symptoms of low blood sugar may include:
- fast heart beat
- feeling jittery
Talk with your healthcare provider about how to treat low blood sugar.
Kidney problems. Bydureon may cause new or worse problems with kidney function, including kidney failure. Dialysis or kidney transplant may be needed. While taking Bydureon: Call your healthcare provider right away if you have:
- diarrhea that will not go away
- or if you cannot take liquids by mouth. You may be at increased risk for kidney problems.
Severe allergic reactions can happen with Bydureon. Stop taking Bydureon, and get medical help right away if you have any symptom of a severe allergic reaction. Do not use Bydureon if you have had an allergic reaction to Bydureon or any of the other ingredients in it.
Symptoms of a severe allergic reaction with Bydureon may include:
- swelling of your face, lips, tongue, or throat
- problems breathing or swallowing
- severe rash or itching
- fainting or feeling dizzy
- very rapid heartbeat
Pancreatitis. Bydureon may cause inflammation of the pancreas (pancreatitis), a potentially life-threatening condition. Tell your doctor right away if you have severe stomach pain and vomiting.
Do not use Bydureon if:
- you or any of your family members have a history of medullary thyroid cancer
- you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is a disease where people have tumors in more than one gland in their body.
- you have type I diabetes (insulin-dependent). Bydureon is not a form of insulin.
- if you have severe kidney disease, or severe digestive tract conditions
Bydureon Food Interactions
Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Bydureon there are no specific foods that you must exclude from your diet when receiving this medication.
Before receiving Bydureon, tell your doctor about all of your medical conditions including if you:
- have or have had pancreatitis, stones in your gallbladder (gallstones), a history of alcoholism, or high blood triglyceride levels
- have severe problems with your stomach, such as delayed emptying of your stomach (gastroparesis) or problems with digesting food
- have or have had kidney problems, or have had a kidney transplant
- are allergic to any ingredients in this medication
- have medullary thyroid cancer
- have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- have any other medical conditions
Tell your doctor if you are pregnant or breastfeeding.
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Bydureon slows stomach emptying and can affect medicines that need to pass through the stomach quickly.
Bydureon and Pregnancy
Tell your doctor if you are pregnant or plan to become pregnant.
The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.
Bydureon falls into category C. In animal studies, pregnant animals were given this medication and had some babies born with problems. No well-controlled studies have been done in humans, though. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.
Pregnancy Registry: Talk to your doctor about enrolling in the pregnancy registry for women who take this medication during pregnancy. The purpose of this registry is to collect information about the health of you and your baby.
Bydureon and Lactation
It is not known if Bydureon crosses into human milk.
Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Bydureon.
Take Bydureon exactly as prescribed.
Bydureon is a long acting subcutaneous injection given once every seven days (weekly) any time during the day, with or without meals.
Bydureon comes as a dry powder to be mixed with a liquid and must be injected right after you mix it into your stomach area (abdomen), your thigh, or the back of your upper arm. You may use the same area of your body each week, but be sure to choose a different injection site within the area.
Bydureon BCise comes as a premixed and prefilled autoinjector (automatic injecting pen).
If you miss a dose of Bydureon, it should be taken as soon as you remember, provided the next regularly scheduled dose is due at least three days later. If the next dose is due one or two days later, skip the missed dose. Do not take 2 doses of Bydureon less than 3 days apart.
Follow your healthcare provider's instructions for diet, exercise, and how often to test your blood sugar. If you see your blood sugar increasing during treatment with Bydureon, talk to your healthcare provider as you may need to adjust your current treatment plan for your diabetes.
Talk to your healthcare provider about how to manage high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia), and how to recognize problems that can happen with your diabetes.
Never share your Bydureon with another person. You may give an infection to them, or get an infection from them, and Bydureon may harm them.
Use Bydureon exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.
The Bydureon dose your doctor recommends will be based on the following:
- other medications you are taking
- how you respond to this medication
The recommended dose of Bydureon is 2 mg injected once every seven days (weekly). The dose can be administered at any time of day, with or without meals.
If you use too much Bydureon, call your doctor or local Poison Control Center right away.
- Too much Bydureon can cause your blood sugar to drop quickly and you may have symptoms of low blood sugar. You may need medical treatment right away.
- Too much Bydureon can also cause severe nausea and vomiting.
- Bydureon should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C), up to the expiration date or until preparing for use. Bydureon should not be used past the expiration date. The expiration date can be found on the carton, on the cover of the single-dose tray, or on the pen label.
- Do not freeze Bydureon. Do not use Bydureon if it has been frozen. Protect from light.
- Bydureon can be kept at room temperature not to exceed 77°F (25°C) [see USP Controlled Room Temperature] for no more than a total of 4 weeks, if needed.
- Use the diluent only if it is clear and free of particulate matter.
- After suspension, the mixture should be white to off-white and cloudy.
- Bydureon must be administered immediately after the powder is suspended in the diluent.
- Use a puncture-resistant container to discard Bydureon with the needle still attached. Do not reuse or share needles or syringes.
- Keep out of the reach of children.
Bydureon FDA Warning
WARNING: RISK OF THYROID C-CELL TUMORS
- Bydureon causes an increased incidence in thyroid C-cell tumors at clinically relevant exposures in rats compared to controls. It is unknown whether Bydureon causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as human relevance could not be determined by clinical or nonclinical studies.
- Bydureon is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Routine serum calcitonin or thyroid ultrasound monitoring is of uncertain value in patients treated with Bydureon. Patients should be counseled regarding the risk and symptoms of thyroid tumors.